For citations:

Avxentyev N.A., Vasyukova O.V., Drapkina O.M., Drozdova L.Yu., Zyryanov S.K., Kovaleva E.R., Makarov A.S., Makarova Yu.V., Rozenson O.L., Salukhov V.V., Sineglazova A.V., Sukhareva O.Y., Shestakova M.V. Clinical and economic evaluation of extended-release metformin for the treatment of prediabetes and its impact on the budget and target indicators of federal healthcare projects. Diabetes mellitus. 2026;29(2):169-182. (In Russ.) https://doi.org/10.14341/DM13471